Leukocytopenia due to zidovudine- and nevirapine-containing regimens in elderly patients with HIV infection.
Yamamoto
Y
Y
AIDS Clinical Center, International Medical Center of Japan, Tokyo 162-8655, Japan.
Yasuoka
A
A
Yasuoka
C
C
Genka
I
I
Teruya
K
K
Kikuchi
Y
Y
Tachikawa
N
N
Oka
S
S
D000368:Aged; D019380:Anti-HIV Agents / Q000009:adverse effects* / Q000627:therapeutic use; D023241:Antiretroviral Therapy, Highly Active / Q000009:adverse effects; D016049:Didanosine / Q000009:adverse effects / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D017809:Fatal Outcome; D016179:Granulocyte Colony-Stimulating Factor / Q000627:therapeutic use; D015658:HIV Infections / Q000097:blood / Q000150:complications* / Q000188:drug therapy; D015497:HIV-1; D006801:Humans; D007970:Leukopenia / Q000139:chemically induced* / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D019829:Nevirapine / Q000009:adverse effects* / Q000627:therapeutic use; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects / Q000627:therapeutic use; D015215:Zidovudine / Q000009:adverse effects* / Q000627:therapeutic use
D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D016179:Granulocyte Colony-Stimulating Factor; D015215:Zidovudine; D019829:Nevirapine; D016049:Didanosine